JP2020524697A5 - - Google Patents
Info
- Publication number
- JP2020524697A5 JP2020524697A5 JP2019571018A JP2019571018A JP2020524697A5 JP 2020524697 A5 JP2020524697 A5 JP 2020524697A5 JP 2019571018 A JP2019571018 A JP 2019571018A JP 2019571018 A JP2019571018 A JP 2019571018A JP 2020524697 A5 JP2020524697 A5 JP 2020524697A5
- Authority
- JP
- Japan
- Prior art keywords
- abuse
- pharmaceutical composition
- solid pharmaceutical
- oral solid
- alkalizing agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201621044051 | 2017-06-23 | ||
| IN201621044051 | 2017-06-23 | ||
| PCT/IN2018/050410 WO2018235104A2 (en) | 2017-06-23 | 2018-06-22 | Abuse deterrent oral solid dosage form |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524697A JP2020524697A (ja) | 2020-08-20 |
| JP2020524697A5 true JP2020524697A5 (enExample) | 2022-02-16 |
| JP7125436B2 JP7125436B2 (ja) | 2022-08-24 |
Family
ID=64736917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571018A Expired - Fee Related JP7125436B2 (ja) | 2017-06-23 | 2018-06-22 | 乱用抑止経口固体投与形態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11439600B2 (enExample) |
| EP (1) | EP3641734A4 (enExample) |
| JP (1) | JP7125436B2 (enExample) |
| CN (1) | CN110869007B (enExample) |
| AU (1) | AU2018288071A1 (enExample) |
| CA (1) | CA3067945A1 (enExample) |
| WO (1) | WO2018235104A2 (enExample) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8765178B2 (en) * | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
| CA2665226C (en) | 2006-10-05 | 2014-05-13 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
| GB0808537D0 (en) | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
| RU2011123377A (ru) * | 2008-11-14 | 2012-12-20 | Портола Фармасьютиклз, Инк. | ТВЕРДАЯ КОМПОЗИЦИЯ ДЛЯ КОНТРОЛИРУЕМОГО ВЫСВОБОЖДЕНИЯ АКТИВНЫХ ИОНИЗИРУЕМЫХ АГЕНТОВ, ХАРАКТЕРИЗУЮЩИХСЯ НИЗКОЙ РАСТВОРИМОСТЬЮ В ВОДЕ ПРИ НИЗКИХ ЗНАЧЕНИЯХ pН, И СПОСОБЫ ЕЕ ПРИМЕНЕНИЯ |
| JP2014505736A (ja) * | 2011-02-17 | 2014-03-06 | キューアールエックスファーマ リミテッド | 固体投薬形態の乱用を防止するための技術 |
| CN104968333B (zh) | 2012-11-30 | 2018-07-10 | 阿库拉制药公司 | 活性药物成分的自调节释放 |
| WO2014145195A1 (en) * | 2013-03-15 | 2014-09-18 | Cerovene, Inc. | Pharmaceuticals comprising a ph-dependent component and ph-raising agent |
| WO2015065547A1 (en) * | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
| JP6510628B2 (ja) * | 2014-03-26 | 2019-05-15 | サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド | 乱用防止即時放出性被覆リザーバ固体剤形 |
| CA2910865C (en) * | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
| CA2970065A1 (en) * | 2014-12-08 | 2016-06-16 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
| WO2016120892A1 (en) | 2015-01-29 | 2016-08-04 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent controlled release solid dosage form |
| WO2017009865A1 (en) | 2015-07-10 | 2017-01-19 | Sun Pharma Advanced Research Company Ltd. | Multiple pill abuse-resistant immediate release solid dosage form of hydrocodone |
| US20170157052A1 (en) * | 2015-12-08 | 2017-06-08 | Cima Labs Inc. | Immediate release dosage forms that deter abuse by oral ingestion of multiple dosage units |
-
2018
- 2018-06-22 JP JP2019571018A patent/JP7125436B2/ja not_active Expired - Fee Related
- 2018-06-22 CN CN201880042133.1A patent/CN110869007B/zh not_active Expired - Fee Related
- 2018-06-22 AU AU2018288071A patent/AU2018288071A1/en not_active Abandoned
- 2018-06-22 US US16/625,271 patent/US11439600B2/en active Active
- 2018-06-22 CA CA3067945A patent/CA3067945A1/en active Pending
- 2018-06-22 EP EP18820399.6A patent/EP3641734A4/en not_active Withdrawn
- 2018-06-22 WO PCT/IN2018/050410 patent/WO2018235104A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5592547B2 (ja) | 薬物送達組成物 | |
| JP2018058885A5 (enExample) | ||
| JP2017532363A5 (enExample) | ||
| JP2013545762A5 (enExample) | ||
| CN104288774B (zh) | 一种肠溶包衣、富马酸二甲酯肠溶制剂及其制备方法 | |
| CN1384740A (zh) | 含有曲马朵糖精盐的持续释放给药剂型 | |
| JP2007528388A5 (enExample) | ||
| US20050169996A1 (en) | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures | |
| JP7057365B2 (ja) | ミドドリンの組成物およびその使用方法 | |
| RU2000131592A (ru) | Фармацевтическая композиция, покрытая энтеросолюбильной оболочкой, и способ ее получения | |
| US9861585B2 (en) | Osmotic floating tablets | |
| JP2010519201A (ja) | シロスタゾールを含む制御放出製剤及びその製造方法 | |
| JP2009532388A5 (enExample) | ||
| IL161628A (en) | Oral pharmacy preparation containing internal and different external wraps that dissolve in a ph-dependent manner | |
| JP2008508317A5 (enExample) | ||
| JP2011502140A5 (enExample) | ||
| CA2877190C (en) | Medicament form for release of active ingredients | |
| CN101485644A (zh) | 一种新型控释胶囊剂及其制备方法 | |
| JP2011502140A (ja) | トルテロジンの制御放出型医薬組成物 | |
| CN103006612B (zh) | 一种赖诺普利迟释缓释片剂及其制备方法 | |
| KR20070069105A (ko) | 서방성 제제 | |
| JP2009534441A (ja) | ピリジルメチルスルフィニルベンズイミダゾールのための経口速放医薬製剤 | |
| EP2549985A1 (en) | Stable pharmaceutical compositions comprising fesoterodine | |
| CN102112115A (zh) | 雷米普利调节释放组合物及其应用 | |
| JP2014508187A (ja) | 選択的セロトニン再取り込み阻害薬の放出制御医薬組成物 |